ARS Pharmaceuticals SPRY
NASDAQ SPRY
$4.19 -0.10 (-2.33%)
As of: Oct 21, 2026 · 3:51 PM EDT

ARS Pharmaceuticals (SPRY) EV to CFO (2022 - 2024)

Updated

ARS Pharmaceuticals' (SPRY) EV to CFO stood at 53.10 in Q4 2024.

Analysis

ARS Pharmaceuticals (SPRY) EV to CFO (2022 - 2024) Analysis & Trends

  • The Q4 2024 figure is the lowest quarterly EV to CFO since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,135.76 Bn 1,104.34 Bn 19.71 Bn
2 Johnson & Johnson 619.07 Bn 537.60 Bn 17.26 Bn
3 AbbVie 503.11 Bn 476.22 Bn 12.70 Bn
4 Merck 370.23 Bn 324.61 Bn 12.21 Bn
5 Novartis Ag 298.76 Bn 262.75 Bn 11.24 Bn
6 Astrazeneca 261.14 Bn 234.83 Bn 12.86 Bn
7 Amgen 237.54 Bn 192.94 Bn 7.24 Bn
8 Gilead Sciences 191.65 Bn 165.84 Bn 6.22 Bn
9 Pfizer 170.26 Bn 116.90 Bn 10.94 Bn
10 ARS Pharmaceuticals 416.12 Mn 272.32 Mn 20.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 53.10
Sep 30, 2022 -9.28
API Access

ARS Pharmaceuticals EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=SPRY&period=max&api_key=YOUR_API_KEY